Serveur d'exploration sur l'opéra

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Sequencing analysis of ghrelin gene 5' flanking region : relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index

Identifieur interne : 001927 ( Main/Exploration ); précédent : 001926; suivant : 001928

Sequencing analysis of ghrelin gene 5' flanking region : relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index

Auteurs : Johanna Vartiainen [Finlande] ; Y. Antero Kes Niemi [Finlande] ; Olavi Ukkola [Finlande]

Source :

RBID : Pascal:06-0482496

Descripteurs français

English descriptors

Abstract

Ghrelin is a 28-amino-acid peptide with several functions linked to energy metabolism. Low ghrelin plasma concentrations are associated with obesity, hypertension, and type 2 diabetes mellitus, whereas high concentrations reflect states of negative energy balance. Several studies addressing the hormonal and neural regulation of ghrelin gene expression have been carried out, but the role of genetic factors in the regulation of ghrelin plasma levels remains unclear. To elucidate the role of genetic factors in the regulation of ghrelin expression, we screened 1657 nucleotides of the ghrelin gene 5' flanking region (promoter and possible regulatory sites) for new sequential variations from patient samples with low (n - 50) and high (n = 50) fasting plasma total ghrelin concentrations (low- and high-ghrelin groups). Eleven single nucleotide polymorphisms (SNPs), 3 of which were rare variants (allelic frequency less than 1%) were found in our population. The genotype distribution patterns of the SNPs did not differ between the study groups, except for SNP -501A>C (P =.039). In addition, the SNP -501A>C was associated with body mass index (BMI) (P =.018). This variant was studied further in our large and well-defined Oulu Project Elucidating Risk for Atherosclerosis (OPERA) cohort (n = 1045) by the restriction fragment length polymorphism (RFLP) technique. No significant association of SNP -501A>C genotypes with fasting ghrelin plasma concentrations was found in the whole OPERA population. However, the association of this SNP with BMI and with waist circumference reached statistical significance in OPERA (P =.047 and.049, respectively), remaining of borderline significance for BMI after adjustments (P =.055). The results indicate that factors other than the 11 SNPs found in this study in the 5' flanking region of ghrelin gene are the main determinants of ghrelin plasma levels. However, SNP -501 A>C genotype distribution seems to be different in subjects having the highest compared with those with the lowest ghrelin levels, and the SNP may be associated with BMI and waist circumference.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Sequencing analysis of ghrelin gene 5' flanking region : relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index</title>
<author>
<name sortKey="Vartiainen, Johanna" sort="Vartiainen, Johanna" uniqKey="Vartiainen J" first="Johanna" last="Vartiainen">Johanna Vartiainen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Internal Medicine and Biocenter Oulu, University of Oulu, P.O. Box 5000</s1>
<s2>90014 Oulu</s2>
<s3>FIN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
<wicri:noRegion>90014 Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Antero Kes Niemi, Y" sort="Antero Kes Niemi, Y" uniqKey="Antero Kes Niemi Y" first="Y." last="Antero Kes Niemi">Y. Antero Kes Niemi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Internal Medicine and Biocenter Oulu, University of Oulu, P.O. Box 5000</s1>
<s2>90014 Oulu</s2>
<s3>FIN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
<wicri:noRegion>90014 Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ukkola, Olavi" sort="Ukkola, Olavi" uniqKey="Ukkola O" first="Olavi" last="Ukkola">Olavi Ukkola</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Internal Medicine and Biocenter Oulu, University of Oulu, P.O. Box 5000</s1>
<s2>90014 Oulu</s2>
<s3>FIN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
<wicri:noRegion>90014 Oulu</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">06-0482496</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0482496 INIST</idno>
<idno type="RBID">Pascal:06-0482496</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000369</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000223</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000303</idno>
<idno type="wicri:doubleKey">0026-0495:2006:Vartiainen J:sequencing:analysis:of</idno>
<idno type="wicri:Area/Main/Merge">001962</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16979415</idno>
<idno type="wicri:Area/PubMed/Corpus">000481</idno>
<idno type="wicri:Area/PubMed/Curation">000481</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000461</idno>
<idno type="wicri:Area/Ncbi/Merge">000407</idno>
<idno type="wicri:Area/Ncbi/Curation">000407</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000407</idno>
<idno type="wicri:doubleKey">0026-0495:2006:Vartiainen J:sequencing:analysis:of</idno>
<idno type="wicri:Area/Main/Merge">001832</idno>
<idno type="wicri:Area/Main/Curation">001927</idno>
<idno type="wicri:Area/Main/Exploration">001927</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Sequencing analysis of ghrelin gene 5' flanking region : relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index</title>
<author>
<name sortKey="Vartiainen, Johanna" sort="Vartiainen, Johanna" uniqKey="Vartiainen J" first="Johanna" last="Vartiainen">Johanna Vartiainen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Internal Medicine and Biocenter Oulu, University of Oulu, P.O. Box 5000</s1>
<s2>90014 Oulu</s2>
<s3>FIN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
<wicri:noRegion>90014 Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Antero Kes Niemi, Y" sort="Antero Kes Niemi, Y" uniqKey="Antero Kes Niemi Y" first="Y." last="Antero Kes Niemi">Y. Antero Kes Niemi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Internal Medicine and Biocenter Oulu, University of Oulu, P.O. Box 5000</s1>
<s2>90014 Oulu</s2>
<s3>FIN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
<wicri:noRegion>90014 Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ukkola, Olavi" sort="Ukkola, Olavi" uniqKey="Ukkola O" first="Olavi" last="Ukkola">Olavi Ukkola</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Internal Medicine and Biocenter Oulu, University of Oulu, P.O. Box 5000</s1>
<s2>90014 Oulu</s2>
<s3>FIN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
<wicri:noRegion>90014 Oulu</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Metabolism, clinical and experimental</title>
<title level="j" type="abbreviated">Metab. clin. exp.</title>
<idno type="ISSN">0026-0495</idno>
<imprint>
<date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Metabolism, clinical and experimental</title>
<title level="j" type="abbreviated">Metab. clin. exp.</title>
<idno type="ISSN">0026-0495</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>5' Flanking Region (genetics)</term>
<term>Analysis</term>
<term>Blood plasma</term>
<term>Body Mass Index</term>
<term>Body mass index</term>
<term>Concentration</term>
<term>DNA (genetics)</term>
<term>DNA Primers</term>
<term>Fast</term>
<term>Fasting</term>
<term>Female</term>
<term>Gene</term>
<term>Genetic Variation</term>
<term>Genetics</term>
<term>Genotype</term>
<term>Ghrelin</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nucleotide sequence</term>
<term>Peptide Hormones (blood)</term>
<term>Peptide Hormones (genetics)</term>
<term>Polymorphism, Restriction Fragment Length</term>
<term>Region</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Peptide Hormones</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>DNA</term>
<term>Peptide Hormones</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>5' Flanking Region</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Body Mass Index</term>
<term>DNA Primers</term>
<term>Female</term>
<term>Genetic Variation</term>
<term>Genotype</term>
<term>Ghrelin</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Polymorphism, Restriction Fragment Length</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Séquence nucléotide</term>
<term>Analyse</term>
<term>Gène</term>
<term>Génétique</term>
<term>Région</term>
<term>Jeûne alimentaire</term>
<term>A jeun</term>
<term>Plasma sanguin</term>
<term>Concentration</term>
<term>Indice masse corporelle</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Génétique</term>
<term>Région</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Ghrelin is a 28-amino-acid peptide with several functions linked to energy metabolism. Low ghrelin plasma concentrations are associated with obesity, hypertension, and type 2 diabetes mellitus, whereas high concentrations reflect states of negative energy balance. Several studies addressing the hormonal and neural regulation of ghrelin gene expression have been carried out, but the role of genetic factors in the regulation of ghrelin plasma levels remains unclear. To elucidate the role of genetic factors in the regulation of ghrelin expression, we screened 1657 nucleotides of the ghrelin gene 5' flanking region (promoter and possible regulatory sites) for new sequential variations from patient samples with low (n - 50) and high (n = 50) fasting plasma total ghrelin concentrations (low- and high-ghrelin groups). Eleven single nucleotide polymorphisms (SNPs), 3 of which were rare variants (allelic frequency less than 1%) were found in our population. The genotype distribution patterns of the SNPs did not differ between the study groups, except for SNP -501A>C (P =.039). In addition, the SNP -501A>C was associated with body mass index (BMI) (P =.018). This variant was studied further in our large and well-defined Oulu Project Elucidating Risk for Atherosclerosis (OPERA) cohort (n = 1045) by the restriction fragment length polymorphism (RFLP) technique. No significant association of SNP -501A>C genotypes with fasting ghrelin plasma concentrations was found in the whole OPERA population. However, the association of this SNP with BMI and with waist circumference reached statistical significance in OPERA (P =.047 and.049, respectively), remaining of borderline significance for BMI after adjustments (P =.055). The results indicate that factors other than the 11 SNPs found in this study in the 5' flanking region of ghrelin gene are the main determinants of ghrelin plasma levels. However, SNP -501 A>C genotype distribution seems to be different in subjects having the highest compared with those with the lowest ghrelin levels, and the SNP may be associated with BMI and waist circumference.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Finlande</li>
</country>
</list>
<tree>
<country name="Finlande">
<noRegion>
<name sortKey="Vartiainen, Johanna" sort="Vartiainen, Johanna" uniqKey="Vartiainen J" first="Johanna" last="Vartiainen">Johanna Vartiainen</name>
</noRegion>
<name sortKey="Antero Kes Niemi, Y" sort="Antero Kes Niemi, Y" uniqKey="Antero Kes Niemi Y" first="Y." last="Antero Kes Niemi">Y. Antero Kes Niemi</name>
<name sortKey="Ukkola, Olavi" sort="Ukkola, Olavi" uniqKey="Ukkola O" first="Olavi" last="Ukkola">Olavi Ukkola</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001927 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001927 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    OperaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:06-0482496
   |texte=   Sequencing analysis of ghrelin gene 5' flanking region : relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index
}}

Wicri

This area was generated with Dilib version V0.6.21.
Data generation: Thu Apr 14 14:59:05 2016. Site generation: Thu Oct 8 06:48:41 2020